Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo

 

Unsupported browser: Your browser does not meet modern web standards. See how it scores »

A new set of tools could help patients with chronic illnesses track their condition and monitor  how they respond to different treatments.

The tools are designed to let physicians run experiments tailored to an individual patient’s needs, a faster and more quantitative way than infrequent office visits to determine a treatment’s benefits or side effects.

“The idea is to try to make interactions between patients and doctors more continuous, and to provide patients with more information so they can participate more actively in their care,” says Peter Margolis, a physician at Cincinnati Children’s Hospital. The project is part of the Collaborative Chronic Care Network (C3N), whose goal is to collect real-time data and use it to change how chronic illnesses are managed.

Those involved with the project would like to see health care focused more on the variability of day-to-day life, and less on sporadic visits to the doctor’s office.

Today, most patients with chronic conditions see their physicians a few times a year. The doctor prescribes a new treatment, and the patient reports back weeks or months later. Margolis and his collaborators have created a suite of tools, including automated text messages, smart phone apps, and online surveys, to help patients track their symptoms more rigorously.  Because the tools are designed to generate quantitative data, “we can set up a self-experiment and see if treatments work,” says Margolis.

The project is part of a larger trend of people using new technology to monitor their health. While much of this tracking occurs outside of the traditional health-care system (see The Measured Life), Margolis would like to create a platform that brings both doctors and patients into the process.

“The theory is that if we had more rigorous information on patient outcomes, we would be able to adjust therapies in a more scientifically rigorous way,” says Richard Kravitz, a physician and health policy researcher at the University of California, Davis, who is not involved in the Cincinnati effort.

Margolis’s project will initially focus on children and teens with Crohn’s disease, a painful intestinal disorder, and other inflammatory bowel diseases. It is still in the early design phase; researchers are testing the system on a handful of patients with the goal of deploying it through the 300 physicians of C3N. Part of the early work involves determining what kinds of questions patients ask and the best ways for them to collect information. The tools are designed to be flexible, Margolis says, and therefore they should be applicable to other conditions as well.

0 comments about this story. Start the discussion »

Tagged: Biomedicine, The Measured Life, self-tracking, inflammation, inflammatory bowel disease

Reprints and Permissions | Send feedback to the editor

From the Archives

Close

Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me